CVS HEALTH CORPORATION earnings per share and revenue
On Feb 10, 2026, CVS reported earnings of 1.09 USD per share (EPS) for Q4 25, beating the estimate of 1.00 USD, resulting in a 8.80% surprise. Revenue reached 105.69 billion, compared to an expected 104.63 billion, with a 1.02% difference. The market reacted with a -0.09% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 20 analysts forecast an EPS of 2.25 USD, with revenue projected to reach 95.92 billion USD, implying an increase of 106.42% EPS, and decrease of -9.25% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
SBC Medical Group Holdings Incorporated Common Stock
Report Date
Mar 27, 2026 For Q4 25
Estimate
$0.12
Actual
$0.14
Surprise
+15.51%
So-Young International Inc. - ADR
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.70
Actual
-$0.93
Surprise
-32.59%
OSR Holdings, Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.10
Actual
-$0.16
Surprise
-56.86%
SeaStar Medical Holding Corporation Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$1.07
Actual
-$0.80
Surprise
+25.28%
Synergy CHC Corp. Common Stock
Report Date
Apr 01, 2026 For Q4 25
Estimate
$0.01
Actual
-$0.72
Surprise
-7158.82%
Co-Diagnostics, Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$3.67
Actual
-$3.64
Surprise
+0.87%
FAQ
What were CVS HEALTH CORPORATION's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, CVS HEALTH CORPORATION reported EPS of $1.09, beating estimates by 8.8%, and revenue of $105.69B, 1.02% above expectations.
How did the market react to CVS HEALTH CORPORATION's Q4 2025 earnings?
The stock price moved down -0.09%, changed from $75.77 before the earnings release to $75.70 the day after.
When is CVS HEALTH CORPORATION expected to report next?
The next earning report is scheduled for May 06, 2026.
What are the forecasts for CVS HEALTH CORPORATION's next earnings report?
Based on 20
analysts, CVS HEALTH CORPORATION is expected to report EPS of $2.25 and revenue of $95.92B for Q1 2026.